A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2010-11-16
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the safety and efficacy of SB-742457 when added to
stable donepezil treatment in subjects with mild-to-moderate Alzheimer's disease.